Science Care Biobanking: Expanding the Future of Research
For more than 20 years, Science Care has been the trusted leader in non-transplant human tissue. With the launch of our new Biobanking Division, we’re setting a higher standard for donor-derived research.
Ethical Donors. Global Research. Medical Progress.
By uniting world-class donor programs, deep regulatory expertise, and advanced biobanking operations, we provide clinicians, researchers, and product developers with reliable access to high-quality, ethically sourced biospecimens, empowering the discoveries that drive medical innovation.
Common Questions
How do you ensure ethical sourcing?
All tissue is donated through the Science Care donor program with full informed consent. Our process is transparent, IRB-compliant, and aligned with the highest ethical standards.
What infectious disease testing is performed?
All donors undergo rigorous screening for infectious diseases (including HIV, HBV, HCV). Testing is performed at CLIA-certified labs to ensure sample safety and compliance.
What regulatory standards do you comply with?
Science Care Biobanking operates under FDA 21 CFR Part 1271, and complies with AATB, CLIA, CAP, and HIPAA regulations. This ensures the highest quality and compliance at every step.
Can samples be customized (e.g., tumor type, demographics)?
Yes. We offer flexible customization by disease type, organ, demographics, and other clinical parameters to meet the specific needs of your project.
How quickly can samples be shipped?
Inventory-based biospecimens can often be shipped within days. Custom collections are scheduled according to project timelines, with full transparency on availability and delivery.
Do you support international clients?
Yes. We ship globally, following all import/export and biospecimen transport regulations to ensure secure and compliant international delivery.
How is donor privacy protected?
All biospecimens are fully de-identified in compliance with HIPAA. Donor privacy and confidentiality are safeguarded at every stage.
Common Misconceptions
“Biobanking isn’t regulated enough.”
Science Care meets or exceeds FDA, AATB, and HIPAA requirements, ensuring full regulatory compliance.
“Cadaveric tissue is inconsistent.”
Every sample is rigorously screened, quality-controlled, and annotated for reproducibility and reliability.
“It’s too costly and slow.”
Our global scale and logistics ensure cost-effective pricing and efficient delivery timelines.
“Data isn’t reliable.”
Each biospecimen is delivered with verified, annotated donor metadata, ensuring scientific accuracy and reproducibility.
Science Care Biobanking Division
Ethical Donors. Global Research. Medical Progress.
